Explore how medicinal chemistry is mapping the complex landscape of cancer treatment through innovative approaches like AI-driven drug discovery, RNA Pol 1 inhibition, and covalent modulators.
Explore how quinazoline and quinazolinone hybrids are revolutionizing drug discovery with their multifaceted therapeutic potential against cancer, inflammation, and microbial infections.
How scientists are unlocking the secrets of bioactive compounds from plants and fungi to fight disease through isolation, characterization and biological testing.
Explore how QSAR modeling and artificial neural networks are accelerating the development of PDE10A inhibitors for treating neurological disorders, cancer, and heart conditions.
Explore how photochemical synthesis using dicyanopyrazine (DPZ) catalysts enables sustainable construction of complex xanthene-based pharmaceuticals.
Discover how visible light-promoted synthesis is revolutionizing the creation of bioactive N,N-heterocycles for pharmaceutical applications.
Breakthroughs in trichloroacetimidate etherification chemistry and aminosteroid SHIP inhibitors are solving long-standing challenges in pharmaceutical development.
Exploring how computational approaches are revolutionizing drug discovery by targeting protein-protein interactions through AI, molecular docking, and simulations.
Exploring the revolutionary potential of 1,2,4-triazole scaffolds in modern drug discovery against superbugs, cancer, and other diseases.
Explore how Prof. Claudiu T. Supuran transformed drug discovery through his groundbreaking work on carbonic anhydrase inhibitors, leading to treatments for glaucoma, epilepsy, and cancer.